LINC01585: A Potential Drug Target and Biomarker (G101929765)

Target Name: LINC01585

NCBI ID: G101929765

LINC01585

Other Name(s): Long intergenic non-protein coding RNA 1585 | long intergenic non-protein coding RNA 1585

LINC01585: A Potential Drug Target and Biomarker

LINC01585 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in various tissues and cells of the human body. The function and regulation of LINC01585 are not well understood, but its potential involvement in various diseases and conditions have been proposed. In this article, we will explore the potential drug target and biomarker properties of LINC01585.

Potential Drug Target

LINC01585 has been identified as a potential drug target due to its unique structure and gene expression pattern. It is a long non-coding RNA molecule that contains multiple exons on its 5' and 3' ends. The 3' end of the RNA molecule contains a stem-loop structure that is similar to that of the TATA RNA binding protein (TBP), a key regulator of gene expression. The 5' end of the RNA molecule contains a series of unordered regions that are similar to those of RNA viruses.

The stem-loop region of LINC01585 is highly conserved and is involved in the formation of a closed double-stranded RNA structure. This region has been shown to play a role in the regulation of gene expression by binding to the TBP. Therefore, LINC01585 may be a good candidate for drugs that target the TBP.

Potential Biomarker

LINC01585 has also been identified as a potential biomarker for various diseases and conditions. Its expression has been observed in a variety of tissues and cells, including the brain, heart, liver, and pancreas. It has also been shown to be expressed in various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

One of the potential benefits of LINC01585 as a biomarker is its potential to be used for early disease detection. Since its expression has been observed in a variety of tissues and cells, it may be a useful biomarker for the early detection of disease.

Conclusion

In conclusion, LINC01585 is a long intergenic non-protein coding RNA that has been identified as a potential drug target and biomarker. Its unique structure and gene expression pattern, as well as its potential involvement in the regulation of gene expression by the TBP, make it an interesting candidate for drug development. Additionally, its potential as a biomarker for various diseases and conditions makes it a promising tool for early disease detection. Further research is needed to fully understand the function and regulation of LINC01585 and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1585

The "LINC01585 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01585 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets